Actinogen Medical Limited
ATGGF
$0.025
$0.00525.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | 5.94M | 6.24M | 6.53M | 4.86M | 3.22M |
| Total Revenue | 5.94M | 6.24M | 6.53M | 4.86M | 3.22M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 5.94M | 6.24M | 6.53M | 4.86M | 3.22M |
| SG&A Expenses | 4.89M | 4.83M | 4.75M | 4.71M | 4.70M |
| Depreciation & Amortization | 268.80K | 271.90K | 273.40K | 274.20K | 276.70K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.52M | 13.89M | 15.20M | 14.17M | 13.20M |
| Operating Income | -6.58M | -7.65M | -8.67M | -9.31M | -9.98M |
| Income Before Tax | -6.38M | -7.48M | -8.53M | -9.15M | -9.79M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.38 | -7.48 | -8.53 | -9.15 | -9.79 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.38M | -7.48M | -8.53M | -9.15M | -9.79M |
| EBIT | -6.58M | -7.65M | -8.67M | -9.31M | -9.98M |
| EBITDA | -6.37M | -7.44M | -8.45M | -9.09M | -9.76M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 10.40B | 9.55B | 8.70B | 8.20B | 7.70B |
| Average Diluted Shares Outstanding | 10.40B | 9.55B | 8.70B | 8.20B | 7.70B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |